Cited by 283Nitric Oxide and Endothelin EffectsCardiovascular Health and Disease PreventionEicosanoids and Hypertension Pharmacology

Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases

Napoli, Claudio, Ignarro, Louis J.·2009·Archives of Pharmacal Research

Abstract

Nitric oxide (NO) is a pivotal signaling messenger in the cardiovascular system. NO participates in regulatory functions including control of hemostasis, fibrinolysis, platelet and leukocyte interactions with the arterial wall, regulation of vascular tone, proliferation of vascular smooth muscle cells, and homeostasis of blood pressure. Diminished NO bioavailability and abnormalities in NO-dependent signaling are among central factors of vascular disease, although it is unclear whether this is a cause of, or result of endothelial dysfunction or both pathogenic events. Disturbances in NO bioavailability have been linked to cause endothelial dysfunction, leading to increased susceptibility to atherosclerotic lesion progression, hypertension, hypercholesterolemia, diabetes mellitus, thrombosis and stroke.

Integrity signals

Registry

Crossref · 10.1007/s12272-009-1801-1

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Napoli, C., & Ignarro, L. J.
Affiliations
University of California, Los Angeles (US)
Venue
Archives of Pharmacal Research
Published
2009-08
Volume
32
Issue
8
Pages
1103-1108
ISSN
  • 0253-6269 (ISSN-L)
  • 1976-3786
OpenAlex
W2049131838
Cited by
281
References
37
Citations by year
2026: 4 · 2025: 8 · 2024: 11 · 2023: 5 · 2022: 15 · 2021: 9 · 2020: 15 · 2019: 16 · 2018: 18 · 2017: 20 · 2016: 9 · 2015: 18 · 2014: 23 · 2013: 17 · 2012: 24
FWCI
3.40
Type
journal article
Language
en
Open access
closed
Locations
  • Archives of Pharmacal Research (publishedVersion)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
Keywords
nitric oxide, NO bioavailability, endothelial dysfunction, vascular disease, atherosclerosis, hypertension, hypercholesterolemia, diabetes mellitus, thrombosis, stroke, vascular tone, vascular smooth muscle cell proliferation, hemostasis, fibrinolysis
MeSH terms
Animals, Humans, Nitric Oxide, Oxidation-Reduction, Vascular Diseases, Kruppel-Like Transcription Factors, Nitric Oxide Synthase Type III

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review